Omnimmune OMMH Stock
Omnimmune Price Chart
Omnimmune OMMH Financial and Trading Overview
| Omnimmune stock price | 0.0001 USD |
| Previous Close | 6.7E-5 USD |
| Open | 6.7E-5 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 6.7E-5 - 6.7E-5 USD |
| 52 Week Range | 6.7E-5 - 0.0001 USD |
| Volume | 300 USD |
| Avg. Volume | 300 USD |
| Market Cap | 657 USD |
| Beta (5Y Monthly) | 1.065202 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OMMH Valuation Measures
| Enterprise Value | 2.28M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Omnimmune Stock Price History
| Beta (5Y Monthly) | 1.065202 |
| 52-Week Change | -32.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 6.7E-5 USD |
| 50-Day Moving Average | 8.35E-5 USD |
| 200-Day Moving Average | 8.35E-5 USD |
OMMH Share Statistics
| Avg. Volume (3 month) | 300 USD |
| Avg. Daily Volume (10-Days) | 614 USD |
| Shares Outstanding | 9.81M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2009 |
| Most Recent Quarter (mrq) | September 30, 2010 |
| Next Fiscal Year End | December 31, 2010 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -2075.75% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1794093 USD |
| Diluted EPS (ttm) | -0.199 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.81K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 2.28M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.009 |
| Book Value Per Share (mrq) | -0.611 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -569466 USD |
| Levered Free Cash Flow (ttm) | 429.04K USD |
Profile of Omnimmune
| Country | United States |
| State | TX |
| City | Houston |
| Address | 4600 Post Oak Place |
| ZIP | 77027 |
| Phone | 713-622-8400 |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Q&A For Omnimmune Stock
What is a current OMMH stock price?
Omnimmune OMMH stock price today per share is 0.0001 USD.
How to purchase Omnimmune stock?
You can buy OMMH shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Omnimmune?
The stock symbol or ticker of Omnimmune is OMMH.
Which industry does the Omnimmune company belong to?
The Omnimmune industry is Biotechnology.
How many shares does Omnimmune have in circulation?
The max supply of Omnimmune shares is 140.34M.
What is Omnimmune Price to Earnings Ratio (PE Ratio)?
Omnimmune PE Ratio is now.
What was Omnimmune earnings per share over the trailing 12 months (TTM)?
Omnimmune EPS is -0.01 USD over the trailing 12 months.
Which sector does the Omnimmune company belong to?
The Omnimmune sector is Healthcare.